Biomarkers Discovered That Predict Lung Cancer Patient Response To Therapy

Researchers at UCLA’s Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.The findings, published in the Feb.

More: continued here

Filed under: Lung Cancer on February 7th, 2008